Basic Information
REQUIP TABLET 1 mg
TABLET, FILM COATED
Regulatory Information
SIN11018P
July 13, 1999
Prescription Only
Therapeutic
ORAL
August 10, 2023
June 3, 2025
XN04BC04
Company Information
Active Ingredients
ROPINIROLE HCl EQV ROPINIROLE
Strength: 1 mg
Detailed Information
Contraindications
**Contraindications** Hypersensitivity to ropinirole or to any of the listed excipients.
Indication Information
**Indications** REQUIP is indicated for the treatment of idiopathic Parkinson's disease: - REQUIP may be used alone (without levodopa \[L-Dopa\]) in the treatment of idiopathic Parkinson's disease. - Addition of REQUIP to levodopa may be used to control "on-off" fluctuations and permit a reduction in the total daily dose of L-Dopa. REQUIP is indicated for the treatment of moderate to severe primary Restless Legs Syndrome (RLS).